按药物类别、动物类型、剂型和地区分類的动物用药品化合物市场

2025 年全球动物用药品化合物市场规模估计为 22.9 亿美元，预计到 2032 年将达到 42.2 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 9.1%。

数字。 2025年动物用药品化合物市场占有率（按地区划分）

动物用药品可根据个别动物患者的需要定製药物製剂，在动物保健中发挥重要作用。当 FDA核准的药物不存在患者所需的适当强度或剂型时，最常使用它们。组合药物允许兽医根据宠物的大小、年龄、医疗状况和其他因素制定定製药物和剂量。这种灵活的药物治疗方法可以帮助改善许多动物的治疗效果。

市场动态：

全球动物用药品化合物市场的成长受到过去几年宠物拥有率上升和宠物照护支出增加等因素的推动。宠物饲主对为宠物提供客製化医疗照护的意识不断增强，推动了市场的成长。然而，复方药物缺乏监管和品质标准，带来安全风险，并可能阻碍市场成长。剂量和组合药物配方的灵活性等优势为市场参与者提供了有利可图的机会。 FDA 最近发布的加强这些设施品质监督的指导方针可能会推动市场成长。

本研究的主要特点

• 本报告对全球动物用药品化合物市场进行了详细分析，并提供了预测期（2025-2032 年）的市场规模（十亿美元）和复合年增长率（CAGR%），假设基准年为 2024 年。
• 它揭示了不同领域的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
• 全球动物用药品化合物市场的主要企业是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的分析。
• 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
• 全球动物用药品化合物市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员将透过用于分析全球动物用药品化合物市场的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 影响分析
• 市场趋势
• 主要进展
• 监管情景
• 收购与合作场景
• 资金筹措与投资
• PEST分析
• 波特的分析

第四章全球动物用药品化合物市场-冠状病毒（COVID-19）大流行的影响

• 整体影响
• 政府倡议
• COVID-19 市场影响

5. 2020-2032 年全球动物用药品化合物市场（按药物类别划分）（十亿美元）

• 中枢神经系统药物
• 抗感染剂
• 荷尔蒙和替代品
• 抗发炎剂
• 其他的

6. 2020-2032 年全球动物用药品化合物市场（按动物类型划分）（十亿美元）

• 宠物
• 狗
• 猫
• 其他的
• 家畜

7. 全球动物用药品化合物市场，依配方，2020-2032 年（十亿美元）

• 口服
• 注射
• 其他的

8. 2020-2032 年全球动物用药品化合物市场（按地区划分）（单位：十亿美元）

• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第九章竞争格局

• 公司简介
  • Wedgewood Pharmacy
  • Diamondback Drugs LL
  • Stokes Pharmacy
  • MEDISCA
  • Patterson Companies, Inc.
  • Boehringer Ingelheim
  • Zoetis Inc.
  • Covetrus
  • Virbac
  • Dechra Pharmaceuticals PLC
  • Elanco
  • Kindred Biosciences, Inc.
  • Merck &Co., Inc.
  • Bayer AG
  • Putney, Inc.
  • Norbrook Laboratories Limited
  • Vetoquinol SA
  • Ceva Sante Animale
  • Rood and Riddle Veterinary Pharmacy
  • Mwi Veterinary Supply Co.

第 10 章分析师建议

• 机会
• 分析师观点
• Coherent Opportunity Map

第 11 章参考文献与调查方法

• 参考
• 调查方法

Global Veterinary Drugs Compounding Market is estimated to be valued at USD 2.29 Bn in 2025 and is expected to reach USD 4.22 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.1% from 2025 to 2032.

Figure. Veterinary Drugs Compounding Market Share (%), By Region 2025

Compounded medications play an important role in veterinary medicine by allowing for customized medication preparations tailored to individual animal patients' needs. These are most commonly used when an FDA-approved drug may not exist in the appropriate strength or dosage form required for a patient. Compounded drugs allow veterinarians to create customized medications and doses depending on factors like pet's size, age, or medical condition. This flexible approach to medication can help improve treatment outcomes for many animals.

Market Dynamics:

Global veterinary drugs compounding market growth is driven by factors such as rising pet ownership and increased spending on pet care over the past few years. Growing awareness among pet owners about providing customized medical care to their animals can drive the market growth. However, lack of regulation and quality standards for compounded drugs poses safety risks and can hamper the market growth. Advantages like flexibility in dosages and forms for compounded drugs present lucrative opportunities for market players. Recent FDA guidelines to strengthen quality oversight of these facilities could drive the market growth.

Key features of the study:

• This report provides in-depth analysis of the global veterinary drugs compounding market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global veterinary drugs compounding market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Patterson Veterinary, Chase Pharmaceuticals, Kentucky Performance Products, Animal Medics and Rx3 Compounding
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global veterinary drugs compounding market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary drugs compounding market.

Detailed Segmentation-

• By Drug Class
  • CNS Agents
  • Anti-infective Agents
  • Hormones and Substitutes
  • Anti-inflammatory Agents
  • Others
• By Animal Type
  • Companion Animals
  • Dogs
  • Cat
  • Others
  • Livestock Animals
• By Formulation
  • Oral
  • Injectable
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Wedgewood Pharmacy
  • Diamondback Drugs LL
  • Stokes Pharmacy
  • MEDISCA
  • Patterson Companies, Inc.
  • Boehringer Ingelheim
  • Zoetis Inc.
  • Covetrus
  • Virbac
  • Dechra Pharmaceuticals PLC
  • Elanco
  • Kindred Biosciences, Inc.
  • Merck & Co., Inc.
  • Bayer AG
  • Putney, Inc.
  • Norbrook Laboratories Limited
  • Vetoquinol S.A.
  • Ceva Sante Animale
  • Rood and Riddle Veterinary Pharmacy
  • Mwi Veterinary Supply Co.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Drug Class
  • Market Snapshot, By Animal Type
  • Market Snapshot, By Formulation
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Veterinary Drugs Compounding Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Veterinary Drugs Compounding Market, By Drug Class, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• CNS Agents
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Anti-infective Agents
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hormones and Substitutes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Anti-inflammatory Agents
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Veterinary Drugs Compounding Market, By Animal Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Companion Animals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Dogs
• Cat
• Others
• Livestock Animals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Veterinary Drugs Compounding Market, By Formulation, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Oral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Injectable
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Veterinary Drugs Compounding Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Wedgewood Pharmacy
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Diamondback Drugs LL
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Stokes Pharmacy
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • MEDISCA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Patterson Companies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boehringer Ingelheim
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Zoetis Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Covetrus
  • Virbac
  • Dechra Pharmaceuticals PLC
  • Elanco
  • Kindred Biosciences, Inc.
  • Merck & Co., Inc.
  • Bayer AG
  • Putney, Inc.
  • Norbrook Laboratories Limited
  • Vetoquinol S.A.
  • Ceva Sante Animale
  • Rood and Riddle Veterinary Pharmacy
  • Mwi Veterinary Supply Co.

10. Analyst Recommendation

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact